Sana Biotechnology, Inc. (SANA) Social Stream



Sana Biotechnology, Inc. (SANA): $7.51

1.00 (+15.36%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SANA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 400

in industry

Sana Biotechnology Inc (SANA) Price Targets From Analysts

Use the tables below to see what analysts covering Sana Biotechnology Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $45 $31 $38.666 $8.68 345.46%
2022-01-05 3 $40 $31 $37 $8.68 326.27%
2022-02-03 3 $40 $17 $29.333 $8.68 237.94%
2022-03-18 3 $40 $14 $23.666 $8.68 172.65%
2022-03-29 3 $32 $14 $21 $8.68 141.94%

The Trend in the Analyst Price Target


Over the past 43 weeks, SANA's average price target has gone down $20.33.

Over the past 49 weeks, SANA's average upside potential has been 122.03%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-05 3 45 39 41.330 19.40 113.04%
2021-09-18 3 45 31 37.500 24.98 50.12%
2022-01-05 3 40 31 37.000 13.11 182.23%
2022-02-03 2 40 17 29.333 7.64 283.94%
2022-03-29 3 32 14 21.000 8.16 157.35%

SANA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.83 1 1 1 0 0 3

The Trend in the Broker Recommendations


SANA's average broker recommendation rating improved by 0 over the prior 120 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Sana Biotechnology Inc's number of analysts covering the stock is greater than 60.41% of them.
  • In the context of all US stocks, Sana Biotechnology Inc's upside potential (average analyst target price relative to current price) is greater than 536.2% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, Sana Biotechnology Inc's variance in analysts' estimates is lower than -330.83% of them.
  • In the context of stocks in the mid market cap category, Sana Biotechnology Inc's average analyst price target is greater than 205.82% of them.

In the Pharmaceutical Products industry, RXRX, RVMD, and RUBY are the three stocks most similar to Sana Biotechnology Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for SANA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4989 seconds.